0001209191-19-009273.txt : 20190212 0001209191-19-009273.hdr.sgml : 20190212 20190212160540 ACCESSION NUMBER: 0001209191-19-009273 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190208 FILED AS OF DATE: 20190212 DATE AS OF CHANGE: 20190212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Invesco Ltd. CENTRAL INDEX KEY: 0000914208 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36754 FILM NUMBER: 19590771 BUSINESS ADDRESS: STREET 1: 1555 PEACHTREE STREET NE STREET 2: SUITE 1800 CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-892-0896 MAIL ADDRESS: STREET 1: 1555 PEACHTREE STREET NE STREET 2: SUITE 1800 CITY: ATLANTA STATE: GA ZIP: 30309 FORMER NAME: FORMER CONFORMED NAME: Invesco Ltd DATE OF NAME CHANGE: 20080508 FORMER NAME: FORMER CONFORMED NAME: Invesco PLC DATE OF NAME CHANGE: 20080429 FORMER NAME: FORMER CONFORMED NAME: Invesco Ltd. DATE OF NAME CHANGE: 20071205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evofem Biosciences, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 550-1900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Neothetics, Inc. DATE OF NAME CHANGE: 20140905 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-08 0 0001618835 Evofem Biosciences, Inc. EVFM 0000914208 Invesco Ltd. 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 0 0 1 0 Common stock 2019-02-08 4 P 0 425531 2.64 A 9590688 I See Footnote Warrants 5.20 2019-02-08 4 P 0 212765 0.0001 A 2026-02-08 Common Stock 212765 212765 I see footnote Invesco Ltd. is the beneficial owner of 9,590,688 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund. The warrants are exercisable on the earlier of 08/08/2019, or following the date that the issuance of the warrants is approved by the stockholders of the Issuer. Nancy Tomassone, Global Assurance Officer 2019-02-12